Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02556294 · ClinicalTrials.gov registry record · NA
Fostering Resilience to Psychosocial and HIV Risk in Indian MSM
A NA study, sponsored by Massachusetts General Hospital.
- Completed
- Registry status
- NA
- Development phase
- 608
- Enrollment target
NCT02556294: Completed NA study, sponsored by Massachusetts General Hospital.
NCT02556294 is a NA study that has completed, run by Massachusetts General Hospital. The registered enrollment target is 608 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02556294, a NA study, has completed, sponsored by Massachusetts General Hospital.
- COMPLETED
- Registry status
- NA
- Development phase
- 608 participants
- Enrollment target
Study Summary
India has the world's third largest HIV epidemic and men who have sex with men (MSM) are an identified high risk group. MSM in India face unique psychosocial stress underlying the context of HIV risk. To maximize the potential impact of an HIV prevention intervention, the purpose of this study is to test, in a two-arm randomized controlled efficacy trial, a behavioral intervention that addresses both psychosocial / contextual stress and reducing participant's risk for HIV.
Interventions
- BEHAVIORAL Self-acceptance based intervention
- BEHAVIORAL HIV/STI counseling and testing
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 608 participants |
| Start Date | 2015-06 |
| Est. Completion | 2019-08 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02556294
The ClinicalTrials.gov registry entry for NCT02556294 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 608 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Massachusetts General Hospital, which has 2,032 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Self-acceptance based intervention is the first listed.
NCT02556294 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02556294 about?
NCT02556294 is a clinical study titled "Fostering Resilience to Psychosocial and HIV Risk in Indian MSM". India has the world's third largest HIV epidemic and men who have sex with men (MSM) are an identified high risk group. MSM in India face unique psychosocial stress underlying the context of HIV risk. To maximize the potential impact of an HIV prevention intervention, the purpose of this study is to...
What is the current status of trial NCT02556294?
This trial is currently completed. It is a NA study. The enrollment target is 608 participants. The study started on 2015-06. Estimated completion is 2019-08.
What interventions are being tested in trial NCT02556294?
The interventions under investigation include: Self-acceptance based intervention (BEHAVIORAL), HIV/STI counseling and testing (BEHAVIORAL).
Who is sponsoring clinical trial NCT02556294?
This trial is sponsored by Massachusetts General Hospital, which has 2,032 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.